During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade also check out my Top 2011 Stock Gainers , Stocks to Buy 2012.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow +1.47% to 12397. S&P +1.5% to 1276. Nasdaq +1.89% to 2321.
Treasurys: 30-year -0.8%. 10-yr -0.37%. 5-yr -0.16%.
Commodities: Crude +3.34% to $103.03. Gold +2.13% to $1604.45.
Currencies: Euro +0.94% vs. dollar. Yen -0.32%. Pound -0.88%
After Hours News:
TiVo (TIVO) jumps 14.9% AH after AT&T (T +0.2% AH) agrees to pay about $215M to settle a patent lawsuit - about $51M up front and regular payments through 2018.
Landec (LNDC) beat FQ2 expectations on a 63% Y/Y jump in profit, as the packaging company's Apio food-products business benefited from higher volume and solid export growth. Shares +4.2% AH.
UQM Technologies (UQM) receives an order for 100 additional PowerPhase HD Select 200 systems from Electric Vehicles International (EVI) that will drive its all-electric UPS delivery vans. Shares +1.4% AH
Team Inc. (TISI) FQ2 beats across-the-board as earnings rose 28% Y/Y on double-digit revenue growth across its major geographic markets. The company also raises its FY12 EPS estimate to $1.55 - $1.70, and its revenue view to $585 - $610M. Shares +3.7% AH
Acme Packet (APKT) lowers guidance, seeing 2011 revenue of $308M-$310M against consensus of $318M. EPS are lowered to $1.03-$1.05 against consensus of $1.14. "Our results were impacted by uncertainty in the North American service provider market," says CEO Andy Ory. Shares to resume trading momentarily.Acme Packet (APKT) resumes trading after cutting guidance. Shares -20% AH
Landec (LNDC) beat FQ2 expectations on a 63% Y/Y jump in profit, as the packaging company's Apio food-products business benefited from higher volume and solid export growth. Shares +4.2% AH.
UQM Technologies (UQM) receives an order for 100 additional PowerPhase HD Select 200 systems from Electric Vehicles International (EVI) that will drive its all-electric UPS delivery vans. Shares +1.4% AH
Team Inc. (TISI) FQ2 beats across-the-board as earnings rose 28% Y/Y on double-digit revenue growth across its major geographic markets. The company also raises its FY12 EPS estimate to $1.55 - $1.70, and its revenue view to $585 - $610M. Shares +3.7% AH
Acme Packet (APKT) lowers guidance, seeing 2011 revenue of $308M-$310M against consensus of $318M. EPS are lowered to $1.03-$1.05 against consensus of $1.14. "Our results were impacted by uncertainty in the North American service provider market," says CEO Andy Ory. Shares to resume trading momentarily.Acme Packet (APKT) resumes trading after cutting guidance. Shares -20% AH
Progress Software (PRGS) beats Q4 estimates, reporting an EPS of $0.34 on revenue of $136M. The company lowers guidance for FQ1 however, now seeing an EPS of $0.25 on revenue of $120M, below consensus EPS expectations of $0.38 on $132M in revenue. Shares -6.5% AH
National Instruments (NATI) says it expects its Q4 revenue to miss expectations, citing a slowdown in revenue growth in Europe. It now says revenue will be around $277M, below its October estimate of $282 - $302M. Shares -6% AH.
Biopharmaceutical developer Amarin (AMRN) dips in after-hours trading after announcing its wholly owned Irish subsidiary, Corsicanto Limited, has commenced a $150M debt offering of exchangeable senior notes due 2032. Shares -8.5% AH.
BioMimetic Therapeutics (BMTI) tanks in the post-trading session after the FDA says its proposed bone-graft device, Augment, wouldn't be approved without more information from previous studies. The company says it plans to submit the necessary information by the middle of the year. Shares -10.7% AH
National Instruments (NATI) says it expects its Q4 revenue to miss expectations, citing a slowdown in revenue growth in Europe. It now says revenue will be around $277M, below its October estimate of $282 - $302M. Shares -6% AH.
Biopharmaceutical developer Amarin (AMRN) dips in after-hours trading after announcing its wholly owned Irish subsidiary, Corsicanto Limited, has commenced a $150M debt offering of exchangeable senior notes due 2032. Shares -8.5% AH.
BioMimetic Therapeutics (BMTI) tanks in the post-trading session after the FDA says its proposed bone-graft device, Augment, wouldn't be approved without more information from previous studies. The company says it plans to submit the necessary information by the middle of the year. Shares -10.7% AH
http://daytradingstock-blog.blogspot.com/
